The Efficacy of Computerized Alcohol Screening and Intervention (CASI) in At-Risk Emergency Department and Trauma Patients (CASI)
|ClinicalTrials.gov Identifier: NCT01680614|
Recruitment Status : Completed
First Posted : September 7, 2012
Last Update Posted : October 26, 2017
The purpose of this research is to examine the effectiveness of computerized alcohol screening and brief intervention in the UC Irvine Medical Center Emergency Department (ED) and Trauma Patients. Brief interventions have a high potential impact in ED and Trauma populations. Computerized alcohol screening and brief intervention (CASI) is a fast and easy to use tool for patients and healthcare providers. CASI mitigates barriers to proper screening and intervention, including time, availability of trained personnel, patient comfort, and language barriers. CASI provides the Alcohol Use Disorders Identification Test (AUDIT) followed by a brief intervention and customized alcohol intake recomendations for the patient.
The intervention of this study will be the addition of a brief CASI questionnaire to the standard of care for a random subset of subjects. All subjects who screen positive for hazardous alcohol use will be followed up and reassessed for alcohol use. The researchers hypothesize that the addition of CASI will lead to a decrease in alcohol intake within three months. The basis of this research is evidence of the effectiveness in the CASI system, the growing public health issue of alcohol abuse, the need to be able to provide effective screening and brief intervention in the high volume ED settings, and findings that the primary method to reduce traumatic death is prevention.
|Condition or disease||Intervention/treatment|
|Alcohol Consumption||Behavioral: CASI|
|Study Type :||Observational|
|Actual Enrollment :||2114 participants|
|Actual Study Start Date :||January 1, 2013|
|Actual Primary Completion Date :||June 1, 2015|
|Study Completion Date :||June 29, 2015|
At Risk Adult Drinkers
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01680614
|United States, California|
|UC Irvine Medical Center|
|Orange, California, United States, 92868|